Test Code: ONC005
BAP1 Associated Tumour Predisposition Syndrome
Oncogenetics
BAP1‑Associated Tumour Predisposition Syndrome (BAP1‑TPDS) is a hereditary cancer syndrome caused by pathogenic variants in the BAP1 gene. Individuals with BAP1‑TPDS have an increased lifetime risk of developing several malignancies, often at younger ages than the general population.
Early identification of a BAP1 pathogenic variant enables proactive surveillance, early tumour detection, and informed management for both patients and at‑risk family members.
Early identification of a BAP1 pathogenic variant enables proactive surveillance, early tumour detection, and informed management for both patients and at‑risk family members.
Sample Type
Blood in EDTA; Bone marrow (Na Heparin Tube)
Turnaround Time
3 - 4 weeks days
Courier Requirements
Ship overnight at room temperature to receive next day. Maintain specimen at room temperature.
Pricing
Login to view pricing
Genes Analyzed
1 genes
BAP1
Methodology
Capture-based target enrichment and Next Generation Sequencing.
Need Help with This Test?
Our team of board-certified genomic scientists is available to answer your questions about test selection, sample requirements, and result interpretation.